Ad is loading...
FSSNX
Price
$30.08
Change
+$0.54 (+1.83%)
Updated
Nov 22 closing price
LGSCX
Price
$13.96
Change
+$0.25 (+1.82%)
Updated
Nov 22 closing price
Ad is loading...

FSSNX vs LGSCX

Header iconFSSNX vs LGSCX Comparison
Open Charts FSSNX vs LGSCXBanner chart's image
Fidelity Small Cap Index
Price$30.08
Change+$0.54 (+1.83%)
VolumeN/A
CapitalizationN/A
Franklin U.S. Small Cap Equity FI
Price$13.96
Change+$0.25 (+1.82%)
VolumeN/A
CapitalizationN/A
FSSNX vs LGSCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSSNX vs. LGSCX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a Buy and LGSCX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 26.9B vs. LGSCX (110M). FSSNX pays higher dividends than LGSCX: FSSNX (1.36) vs LGSCX (0.11). FSSNX was incepted earlier than LGSCX: FSSNX (13 years) vs LGSCX (22 years). LGSCX is a more actively managed with annual turnover of: 34.00 vs. FSSNX (9.00). FSSNX (0) and LGSCX (0) have matching initial minimum investment requirements. FSSNX annual gain was more profitable for investors over the last year : 36.08 vs. LGSCX (30.59). FSSNX return over 5 years is better than : 54.79 vs. LGSCX (27.41).
FSSNXLGSCXFSSNX / LGSCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years22 years-
Gain YTD20.28919.339105%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets26.9B110M24,455%
Annual Yield % from dividends1.360.111,268%
Returns for 1 year36.0830.59118%
Returns for 3 years5.63-13.80-41%
Returns for 5 years54.7927.41200%
Returns for 10 years94.281.665,690%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPTI0.850.07
+8.67%
Karyopharm Therapeutics
PTPI0.270.01
+5.02%
Petros Pharmaceuticals
LGND119.192.64
+2.27%
Ligand Pharmaceuticals
TXO18.240.23
+1.28%
TXO Partners LP
RVMD56.75-0.03
-0.05%
Revolution Medicines